Smith & Nephew expands wound care offering with Healthpoint buy

11/29/2012 | Bloomberg

Smith & Nephew has agreed to pay $782 million to acquire Healthpoint Biotherapeutics, maker of the Santyl ointment used to debride wounds of dead tissue. The deal is expected to allow Smith & Nephew to gain a foothold in the bioactive wound care market and strengthen its advanced wound management business, CEO Olivier Bohuon said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care